Page 8 - Algert Global News Today

First Foundation (NASDAQ:FFWM – Free Report) had its price target lowered by Wedbush from $8.00 to $7.00 in a research note released on Friday, Benzinga reports. Wedbush currently has a neutral rating on the bank’s stock. Wedbush also issued estimates for First Foundation’s Q2 2024 earnings at $0.04 EPS, FY2024 earnings at $0.30 EPS, Q1 […]

B. Riley initiated coverage on shares of Gambling.com Group (NASDAQ:GAMB – Free Report) in a report published on Friday, StockNewsAPI reports. The firm issued a buy rating and a $14.50 price target on the stock. B. Riley also issued estimates for Gambling.com Group’s Q1 2025 earnings at $0.19 EPS, Q2 2025 earnings at $0.18 EPS, […]

Arhaus, Inc. (NASDAQ:ARHS – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eight research firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among analysts […]

Jennison Associates LLC acquired a new stake in Cinemark Holdings, Inc. (NYSE:CNK – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 44,345 shares of the company’s stock, valued at approximately $625,000. A number of other institutional investors and hedge […]

Marquette Asset Management LLC purchased a new stake in NETGEAR, Inc. (NASDAQ:NTGR – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 8,649 shares of the communications equipment provider’s stock, valued at approximately $126,000. Other hedge funds have also modified their holdings […]

Sage Therapeutics (NASDAQ:SAGE – Free Report) had its price target reduced by Truist Financial from $22.00 to $18.00 in a research note published on Friday, Benzinga reports. They currently have a hold rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently issued reports on SAGE. Scotiabank decreased their price objective […]

Wedge Capital Management L L P NC increased its holdings in shares of Preferred Bank (NASDAQ:PFBC – Free Report) by 12.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,031 shares of the bank’s stock after purchasing an additional 874 […]

Sage Therapeutics (NASDAQ:SAGE – Free Report) had its target price decreased by Truist Financial from $22.00 to $18.00 in a research report sent to investors on Friday, Benzinga reports. Truist Financial currently has a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also commented on SAGE. Canaccord Genuity Group decreased their price […]

Preferred Bank (NASDAQ:PFBC – Free Report) – DA Davidson issued their Q2 2024 earnings per share estimates for Preferred Bank in a research note issued on Thursday, April 25th. DA Davidson analyst G. Tenner expects that the bank will earn $2.48 per share for the quarter. The consensus estimate for Preferred Bank’s current full-year earnings […]

Preferred Bank (NASDAQ:PFBC – Free Report) – Investment analysts at DA Davidson issued their Q2 2024 earnings estimates for shares of Preferred Bank in a research note issued to investors on Thursday, April 25th. DA Davidson analyst G. Tenner anticipates that the bank will post earnings per share of $2.48 for the quarter. The consensus […]